Acclinate-logo
Talk to Our Team

Clinical research requires trust between the patient and the pharmaceutical companies. When that trust has been damaged, patients will avoid participating in trials. 

Historically, trust between the Black community and the medical establishment – and medical researchers in particular – has been low. A legacy of unethical behavior and exploitation has caused mistrust. However, clinical researchers and pharmaceutical companies need the participation of communities of color for diversity in clinical trials, but with trust eroded by past abuses, clinical trial recruitment challenges persist.

To overcome these challenges, researchers need to first reach the Black community to proactively rebuild trust. That means connecting with communities of color where they are, including partnering with leaders in those communities willing to further medical education. After all, patients are more likely to trust people who share their background. (If your city leader, neighbor, or trusted peer says a clinical trial is safe, you are likely to believe them.)  

Acclinate’s initiative NOWINCLUDED is helping to create the change necessary to overcome clinical research challenges. NOWINCLUDED is a health education and patient engagement community created by and for the Black/African American community. Ambassadors for NOWINCLUDED speak about clinical research in an open, honest way that’s accessible to community members.  

By accessing clinical trial services such as NOWINCLUDED, pharmaceutical companies and researchers can tap into the support needed to rebuild trust and build more health equity in pharma. 

The Importance of Affective Trust 

Successfully rebuilding trust means focusing on what’s known as “affective trust” rather than “cognitive trust.” While cognitive trust is based on reason, affective trust is based on a genuine emotional connection. These emotional connections often make feelings of trust stronger. 

Any diversity strategy and action plan for clinical researchers must be founded on this principle. It’s essential to engage directly with a community by showing respect and a willingness to work together to build affective trust.  

This involves connecting with community members who are already respected and accepting their help to get the word out about patient resources and education. It also requires communicating in a way that’s clear, honest, and transparent. Partnering with community leaders who are willing to educate patients about clinical trial participation is one of the most impactful things researchers can do to build affective trust and promote patient engagement in the pharmaceutical industry.  

NOWINCLUDED Ambassadors: From the Community and For the Community 

The time, dedication, and resources needed to find Black community leaders willing to partner with clinical research organizations can be significant. Fortunately, NOWINCLUDED does this work already. 

At its heart, NOWINCLUDED is a digital community where patients from communities of color can learn more about specific health conditions, empower informed health decisions and gain valuable support from within the Black community. It provides educational resources, community groups dedicated to specific health concerns, and information about clinical research opportunities.  

In addition to their patient communities, NOWINCLUDED’s most powerful resources are its ambassadors, patients with various diagnoses who are willing to share stories of their healthcare journeys and information about their challenges and victories. Many of these ambassadors have participated in clinical research, and their voices are essential for helping patients from communities of color realize affective trust. NOWINLUDED ambassadors connect with patients 1:1, but they also share videos, conduct webinars, provide Q&As, and attend in- person events, where they meet with patients at healthcare and civic events. 

Tamara Mobley is one such ambassador. Tamara was diagnosed with multiple myeloma 14 years ago. Now, she gives back to her community by sharing her treatment journey on NOWINCLUDED. 

“I really wanted to provide hope, provide a space for people to see themselves,” Mobley says, explaining why she chose to become a NOWINCLUDED ambassador. So far, she has shared her experiences through videos, Q&As, and one-on-one conversations with fellow multiple myeloma patients.  

By telling her story, Mobley helps people like her understand how to navigate this condition that disproportionately affects Black patients, including providing them with resource materials and education.  

Growing Clinical Trial Enrollment with Authentic Relationships 

Mobley’s ambassadorship is inspirational, but her experience also illustrates how powerful affective trust can be. “There really is something about shared experiences that lends to a level of trust,” she says. As a result of that trust, she has been able to share insider tips on living with multiple myeloma with a receptive audience — and one with a real need to see that the face of multiple myeloma could also look like theirs. Much of this information is related to the nuances of having multiple myeloma as a younger Black woman, a perspective that is too often missing from the multiple myeloma medical establishment, where often older and mainly white patients are represented in educational materials. 

The trust Mobley cultivated by sharing these tips with NOWINCLUDED’s audience has resulted in real relationships. She tells the story of how she formed a friendship with another woman through NOWINCLUDED: “Someone saw my video on the NOWINCLUDED page and reached out to me directly to have a conversation.” This woman, now a friend, talks with Mobley regularly and they share information and hope about living with the disease.   

“It's one thing to watch a video, but I think Acclinate actually connects the dots in real life,” Mobley adds. “It’s education at first, but then it turns into a relationship.” 

Relationships like this give Mobley the opportunity to share information about clinical research in which she has participated — in a personal and intimate way. Mobley has participated in multiple clinical trials, and she considers those trials to be among the best treatment experiences she has received. Sharing that part of her story with others can help de-mystify the clinical research process.  

“When you have someone that has actually walked in those shoes from beginning to end, I think it just puts a face to it,” Tamara says. “You know how they navigated it; you know how they came to make the decision to participate. I was able to let people know that, many times, you get a heightened level of care when you are on a trial.” 

Through the work of ambassadors like Mobley, NOWINCLUDED and Acclinate are effectively working to break down clinical trial barriers in communities of color while actively empowering communities of color to take an informed approach to healthcare and lend their voices to patient advocacy. 

Improving Your Diversity Strategy and Action Plan with Acclinate 

Patient communities unite on NOWINCLUDED around genuine desires to share healthcare-related support. 

“You want to do things to impact your community, and Acclinate makes it easy for me to do that because they already have a built-in audience, a platform,” Tamara shares. “I have a voice to empower and to help people be advocates for their own health. I'm so appreciative of the NOWINCLUDED community.”    

It’s this kind of interconnected synergy that powers the work that Acclinate’s clinical trial services do to improve diversity in clinical research. In short, improving health equity in pharma begins long before clinical trials do. Improving diversity in clinical research must start with the establishment of trust that facilitates access to the populations traditionally missing from clinical trials.

Acclinate gives pharmaceutical companies access to communities of color, facilitates engagement around trials, and then analyzes the data generated to predict and plan where and when your next effort should happen to create the ongoing representation you need. To learn more, schedule a 1:1 meeting.

Recent Posts

Unpacking the Latest FDA Guidance: Diversity in Clinical Trials for Pharma
3 Min Read

Earlier this year, the U.S. Food and Drug Administration updated its guidance document on collecting race and ethnicity data in clinical trials. The d...

Read More
Clinical Trial Recruitment Strategies that Increase Diversity
3 Min Read

Under 2022’s Food and Drug Omnibus Reform Act, clinical trial sponsors are required tosubmit diversity action plans with pivotal drug studies such as ...

Read More
Using Clinical Trial Services to Connect with Communities of Color
4 Min Read

Clinical research requires trust between the patient and the pharmaceutical companies. When that trust has been damaged, patients will avoid participa...

Read More
Overcome Clinical Trial Recruitment Challenges: Start with Affective Trust
4 Min Read

Inclusive clinical research populations are necessary for a successful study, and new laws are beginning to mandate diversity action plans to promote ...

Read More
Marques Bradley: Coding for a Cause at Acclinate
2 Min Read

When Marques Bradley joined Acclinate amidst the pandemic's uncertainty in October of 2020, it wasn't just another job opportunity; it was a call to m...

Read More
1 Min Read

As we celebrate our four-year anniversary, Acclinate stands at the forefront of a crucial revolution in healthcare—empowering communities of color to ...

Read More
The Consequences of a Lack of Diversity in Clinical Trials
3 Min Read

Your clinical research processes are carefully developed over the years, and the success of your project depends on thoughtful preparation. As pharmac...

Read More
Why Diversity, Equity, and Inclusion in Healthcare Is Vital
4 Min Read

In recent years, organizations in all industries have increased their emphasis on diversity, equity, and inclusion (DE&I). In healthcare, the adde...

Read More
Nurturing Health Equity: A Black History Month Reflection
1 Min Read

As we enter Black History Month, Acclinate proudly reaffirms its commitment to health equity—a mission that is deeply embedded in understanding and ad...

Read More
1 Min Read

‍Birmingham, AL - January 30, 2024 – Acclinate, a trailblazer in advancing health equity through inclusive research, is thrilled to announce its win i...

Read More
Five Ways Pharma Can Support the Importance of Diversity in Healthcare
4 Min Read

In the U.S., Black Americans are three times more likely to die from asthma than whites. There are a number of complex factors that play into this dis...

Read More
Diversity in Healthcare & Clinical Research: Challenges & Opportunities
4 Min Read

Healthcare has a longstanding history of underrepresentation of communities of color. It often begins with the clinical trial process, where longstand...

Read More
Acclinate and Egality Sciences Unite for Health Equity in Hispanic and African American Communities
2 Min Read

In a milestone effort to address the historic underrepresentation of Hispanic and African American communities in clinical research, Acclinate and Ega...

Read More
Unveiling the Path to Inclusivity: DE&I in Clinical Research
1 Min Read

In the dynamic realm of clinical research our commitment to Diversity, Equity, and Inclusion (DE&I) stands as a cornerstone for positive change. A...

Read More
Clinical Trial Diversity: What Does It Really Mean?
3 Min Read

Clinical trials are critical for evaluating the safety and effectiveness of medical devices and pharmaceutical products. The results of trials guide t...

Read More
Acclinate Collaborates with Merck to Increase Clinical Trial Diversity
1 Min Read

Acclinate, an expert in health equity through inclusive research, is collaborating with Merck, known as MSD outside the United States and Canada, to h...

Read More
Clinical Trial Diversity: Unpacking the FDA’s Latest Draft Guidance
3 Min Read

Over the last year and a half, there has been renewed interest from research sponsors to increase diversity in clinical trials. But what is behind thi...

Read More
Celebrating Jasmine Leonard: Acclinate's First NOW Health Equity Award Recipient
2 Min Read

Why NOW? At Acclinate, we believe that the present moment is the most powerful time to drive change. This is why we established the NOW Award, a recog...

Read More
Acclinate partners with Alabama Regional Medical Services
2 Min Read

Acclinate, a leading digital health startup specializing in health equity through inclusive research, is proud to announce a strategic partnership wit...

Read More
Acclinate Hosts Educational Sessions on Artificial Intelligence and Machine Learning (AI/ML)
1 Min Read

BIRMINGHAM, Ala., April 13, 2023 – Acclinate, a digital health company specializing in accessing and engaging communities of color to make better info...

Read More
Acclinate and Savvy Partner to Empower Communities of Color Through Equitable Paid Research Opportunities
2 Min Read

The partnership was formed when the two companies connected on a shared purpose – shaping community experiences through inclusive health opportunities...

Read More
Trialbee and Acclinate to Host Webinar on the 5 Key Trends Poised to Significantly Improve Clinical Trial Patient Diversity in 2023
1 min read

Trialbee and Acllinate will present an informational webinar discussing 5 key trends in diversity for clinical trials in 2023. The webinar aims to pro...

Read More
2 Min Read

CHAPEL HILL, N.C. & BIRMINGHAM, A.L. — Dec. 13, 2022 — Trialbee, the leader in data and technology-based patient recruitment and enrollment for cl...

Read More
NOWINCLUDED Named to Inc.’s 2022 Best in Business List
1 Min Read

Being named to the Inc. 2022 Best in Business list in the Southeast Region category is a major accomplishment for NOWINCLUDED. Recognition of this mag...

Read More
Shayla Wilson joins the Acclinate team
1 Min Read

Acclinate, a leading digital health company, announced today the appointment of Shayla Wilson as Head of Community and Digital Engagement.

Read More
Acclinate selected as an Awardee of Johnson & Johnson's Maternal-fetal Immune Disorders QuickFire Challenge
1 min read

Acclinate has been selected as an awardee in the Maternal-fetal Immune Disorders Quickfire Challenge. The QuickFire Challenges are managed by Johnson ...

Read More
Lightship® and Acclinate Announce Partnership
1 Min Read

Today, we announced our partnership with Lightship®, a leading virtual-first and hybrid provider of clinical research solutions. As partners, we will ...

Read More
Acclinate Wins DPHARM Idol Disrupt 2022
1 min read

DPHARM Idol is an annual competition that recognizes disruptive companies on their technologies and services for their quality, especially for the ben...

Read More
AI/ML: Hero or Villain
3 Min Read

After overhearing a conversation about my company, my 5-year-old niece asked between bites of frosted flakes, “What is A I M L?” I thought about flexi...

Read More
Acclinate's system now patent pending
1 min read

Did you know that Acclinate's system and method of using intelligent AI-based automated determination of clinical trial participation is now patent–pe...

Read More
Clinical Trial Diversity Webinar
1 min read

Achieving sufficient affective trust is necessary for communities of color to feel comfortable participating in clinical research.

Read More
Assessing Pharma's Response to New FDA Guidance on Clinical Trial Diversity
4 Min Read

Today, the U.S. Food and Drug Administration took an important step to increase racial and ethnic diversity in clinical trials by releasing new draft ...

Read More
Camille Pope joins the Acclinate team
1 Min Read

Birmingham, AL ( April 18, 2022) - Acclinate, a leading digital health company, announced the appointment of Camille Pope, PharmD as Chief Medical Lea...

Read More
e-DICT Transforms Clinical Trial Recruitment
2 Min Read

It is common for pharmaceutical companies to carry out thousands of research and clinical trials every year to test new products and drugs. As is the ...

Read More
Healthcare Leaders Join Forces to Transform Digital Clinical Trials Through DEI
1 min read

‍ The Digital Medicine Society (DiMe) announced today a new collaboration with Acclinate, Amgen, GSK, Lightship, Medable, Rubix LS, Sage Bionetworks, ...

Read More
Why Does Minority Participation in Clinical Trials Matter?
3 Min Read

While people of color make up nearly half of the United States population, only a small percentage of them choose to participate in clinical trials – ...

Read More
Time for an industry metric to assess clinical trial diversity
3 Min Read

Racial and ethnic minorities now make up over 42% of the U.S. population. However, the statistics are alarming when we look at corresponding racial an...

Read More
Increased Black Representation
1 Min Read

A medical breach of trust is something that lingers in the minds of Black Americans. From the Tuskegee study to modern mistreatment, the racial landsc...

Read More
Why Black Participation is Important
1 Min Read

Thanks to the endeared Henrietta Lacks, a woman whose cervical cancer cells have majorly contributed to numerous scientific and medical breakthroughs ...

Read More
Why Diversity Initiatives Fail in Clinical Trials
4 Min Read

According to a recent study published in the journal Gastroenterology, Blacks and Hispanics remain noticeably absent from pancreatic cancer clinical t...

Read More
Beacon of hope shines bright on Birmingham
4 Min Read

Dora and I moved to Birmingham in 1993. I was a newly minted Ph.D. from University of Georgia, where I met Dr. Khris McAllister, former Chair of the M...

Read More
Clinical Trials As A Best Treatment Option - Acclinate
2 Min Read

As new trials continue to improve treatment options for patients with all types of cancer, it’s “never too soon to be talking about clinical trials” w...

Read More
Cox Enterprises Social Impact Accelerator Class 2021 - Acclinate
2 Min Read

ATLANTA, Jan. 25, 2021 /PRNewswire/ -- Cox Enterprises has announced the 2021 class of the Cox Enterprises Social Impact Accelerator powered by Techst...

Read More